Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-028937
Filing Date
2016-08-23
Accepted
2016-08-23 15:10:54
Documents
1
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 5838
  Complete submission text file 0001179110-16-028937.txt   7274
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 BATTERY STREET, SUITE 330 SAN FRANCISCO CA 94111
Business Address
Taub Rebecca (Reporting) CIK: 0001423898 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33277 | Film No.: 161847123